Related references
Note: Only part of the references are listed.RdRp inhibitors and COVID-19: Is molnupiravir a good option?
Seyed Mohammad Reza Hashemian et al.
BIOMEDICINE & PHARMACOTHERAPY (2022)
Proteolysis targeting chimeras in antiviral research
Jenny Desantis et al.
FUTURE MEDICINAL CHEMISTRY (2022)
Crystal structure of SARS-CoV-2 main protease in complex with protease inhibitor PF-07321332
Yao Zhao et al.
PROTEIN & CELL (2022)
Design, Synthesis, and Biological Evaluation of Peptidomimetic Aldehydes as Broad-Spectrum Inhibitors against Enterovirus and SARS-CoV-2
Wenhao Dai et al.
JOURNAL OF MEDICINAL CHEMISTRY (2022)
SARS-CoV-2 Neutralizing Antibodies for COVID-19 Prevention and Treatment
Dapeng Li et al.
ANNUAL REVIEW OF MEDICINE (2022)
3CL Protease Inhibitors with an Electrophilic Arylketone Moiety as Anti-SARS-CoV-2 Agents
Sho Konno et al.
JOURNAL OF MEDICINAL CHEMISTRY (2022)
Peptidomimetic α-Acyloxymethylketone Warheads with Six-Membered Lactam P1 Glutamine Mimic: SARS-CoV-2 3CL Protease Inhibition, Coronavirus Antiviral Activity, and in Vitro Biological Stability
Bing Bai et al.
JOURNAL OF MEDICINAL CHEMISTRY (2022)
Covalent narlaprevir- and boceprevir-derived hybrid inhibitors of SARS-CoV-2 main protease
Daniel W. Kneller et al.
NATURE COMMUNICATIONS (2022)
The P132H mutation in the main protease of Omicron SARS-CoV-2 decreases thermal stability without compromising catalysis or small-molecule drug inhibition
Michael Dominic Sacco et al.
CELL RESEARCH (2022)
A Quick Route to Multiple Highly Potent SARS-CoV-2 Main Protease Inhibitors**
Kai S. Yang et al.
CHEMMEDCHEM (2021)
An update on drugs with therapeutic potential for SARS-CoV-2 (COVID-19) treatment
Sylwester Drozdzal et al.
DRUG RESISTANCE UPDATES (2021)
Improved SARS-CoV-2 Mpro inhibitors based on feline antiviral drug GC376: Structural enhancements, increased solubility, and micellar studies
Wayne Vuong et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)
Discovery of Di- and Trihaloacetamides as Covalent SARS-CoV-2 Main Protease Inhibitors with High Target Specificity
Chunlong Ma et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2021)
Membrane fusion and immune evasion by the spike protein of SARS-CoV-2 Delta variant
Jun Zhang et al.
SCIENCE (2021)
An oral SARS-CoV-2 Mpro inhibitor clinical candidate for the treatment of COVID-19
Dafydd R. Owen et al.
SCIENCE (2021)
Bepridil is potent against SARS-CoV-2 in vitro
Erol C. Vatansever et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
SARS-CoV-2 M-pro inhibitors with antiviral activity in a transgenic mouse model
Jingxin Qiao et al.
SCIENCE (2021)
A small molecule compound with an indole moiety inhibits the main protease of SARS-CoV-2 and blocks virus replication
Shin-ichiro Hattori et al.
NATURE COMMUNICATIONS (2021)
A head-to-head comparison of the inhibitory activities of 15 peptidomimetic SARS-CoV-2 3CLpro inhibitors
Subramanyam Vankadara et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2021)
SARS-CoV-2 Omicron strain exhibits potent capabilities for immune evasion and viral entrance
Xiantao Zhang et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)
Remdesivir and its antiviral activity against COVID-19: A systematic review
Andri Frediansyah et al.
CLINICAL EPIDEMIOLOGY AND GLOBAL HEALTH (2021)
Proteolysis-Targeting Chimeras as Therapeutics and Tools for Biological Discovery
George M. Burslem et al.
CELL (2020)
Learning from the Past: Possible Urgent Prevention and Treatment Options for Severe Acute Respiratory Infections Caused by 2019-nCoV
Jared S. Morse et al.
CHEMBIOCHEM (2020)
Receptor recognition by novel coronavirus from Wuhan: An analysis based on decade-long structural studies of SARS
Yushun Wan et al.
JOURNAL OF VIROLOGY (2020)
Escaping Pandora's Box - Another Novel Coronavirus
David M. Morens et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Responding to Covid-19-A Once-in-a-Century Pandemic?
Bill Gates
NEW ENGLAND JOURNAL OF MEDICINE (2020)
A Novel Coronavirus from Patients with Pneumonia in China, 2019
Na Zhu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Markus Hoffmann et al.
CELL (2020)
Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease
Wenhao Dai et al.
SCIENCE (2020)
Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors
Linlin Zhang et al.
SCIENCE (2020)
PROTAC Technology: Opportunities and Challenges
Hongying Gao et al.
ACS MEDICINAL CHEMISTRY LETTERS (2020)
The COVID-19 Pandemic: A Comprehensive Review of Taxonomy, Genetics, Epidemiology, Diagnosis, Treatment, and Control
Yosra A. Helmy et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors
Zhenming Jin et al.
NATURE (2020)
The development of Coronavirus 3C-Like protease (3CLpro) inhibitors from 2010 to 2020
Yuzhi Liu et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease
Chunlong Ma et al.
CELL RESEARCH (2020)
Could PROTACs Protect Us From COVID-19?
Wilnelly Martinez-Ortiz et al.
DRUG DISCOVERY TODAY (2020)
Discovery of Ketone-Based Covalent Inhibitors of Coronavirus 3CL Proteases for the Potential Therapeutic Treatment of COVID-19
Robert L. Hoffman et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Both Boceprevir and GC376 efficaciously inhibit SARS-CoV-2 by targeting its main protease
Lifeng Fu et al.
NATURE COMMUNICATIONS (2020)
Extensive genetic diversity and host range of rodent-borne coronaviruses
Wen Wang et al.
VIRUS EVOLUTION (2020)
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): An overview of viral structure and host response
Indwiani Astuti et al.
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2020)
PROTACs: An Emerging Therapeutic Modality in Precision Medicine
Dhanusha A. Nalawansha et al.
CELL CHEMICAL BIOLOGY (2020)
severe Acute Respiratory Syndrome Coronavirus-2 SARS-CoV-2 An Update
Mahendra Pal et al.
CUREUS JOURNAL OF MEDICAL SCIENCE (2020)
Targeted protein degradation: elements of PROTAC design
Stacey-Lynn Paiva et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2019)
PROTACs- a game-changing technology
Markella Konstantinidou et al.
EXPERT OPINION ON DRUG DISCOVERY (2019)
Development of targeted protein degradation therapeutics
Philip P. Chamberlain et al.
NATURE CHEMICAL BIOLOGY (2019)
An Overview of Severe Acute Respiratory Syndrome-Coronavirus (SARS-CoV) 3CL Protease Inhibitors: Peptidomimetics and Small Molecule Chemotherapy
Thanigaimalai Pillaiyar et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Epidemiology, Genetic Recombination, and Pathogenesis of Coronaviruses
Shuo Su et al.
TRENDS IN MICROBIOLOGY (2016)
Impact of residues remote from the catalytic centre on enzyme catalysis of copper nitrite reductase
Nicole G. H. Leferink et al.
NATURE COMMUNICATIONS (2014)
Middle East Respiratory Syndrome Coronavirus (MERS-CoV): Announcement of the Coronavirus Study Group
Raoul J. de Groot et al.
JOURNAL OF VIROLOGY (2013)
Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia
Ali Moh Zaki et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Fifteen years of HIV Protease Inhibitors: raising the barrier to resistance
Annemarie M. J. Wensing et al.
ANTIVIRAL RESEARCH (2010)
Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection
Vincent C. C. Cheng et al.
CLINICAL MICROBIOLOGY REVIEWS (2007)
Residues distant from the active site influence protein-tyrosine phosphatase 1B inhibitor binding
J Montalibet et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Programmed ribosomal frameshifting in decoding the SARS-CoV genome
PV Baranov et al.
VIROLOGY (2005)
Molecular model of SARS coronavirus polymerase: Implications for biochemical functions and drug design
X Xu et al.
NUCLEIC ACIDS RESEARCH (2003)
A major outbreak of severe acute respiratory syndrome in Hong Kong
N Lee et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Virus-encoded proteinases and proteolytic processing in the Nidovirales
J Ziebuhr et al.
JOURNAL OF GENERAL VIROLOGY (2000)
Share Paper
